Protective mechanisms of Zanthoxylum Bungeanum essential oil on DSS-induced ulcerative colitis in mice based on colonic mucosal transcriptomic approach

Huan Zhang,Zhiqing Guo,Xiao Wang,Jing Xian,Liang Zou,Chuan Zheng,Jinming Zhang
DOI: https://doi.org/10.1039/d1fo04323d
2022-07-21
Abstract:In this study, we used steam distillation to extract essential oil from the fruits of Zanthoxylum bungeanum Maxim. Based on GC-MS analysis, 45 volatile compounds in ZBEO were determined for its quality control. In vitro studies showed that after pretreatment with ZBEO, the disordered expression levels of pro-inflammatory cytokines (TNF-α, IL-6, and IL-1β) and anti-inflammatory cytokines (IL-10) on colon epithelial NCM460 cells-induced by lipopolysaccharide (LPS) could be called back. Additionally, oral administration of ZBEO significant alleviated colitis in dextran sulfate sodium (DSS)-induced UC mice, including body weight loss, colon length shorting, disease activity index and colonic pathological damage. Furthermore, to uncover the anti-UC mechanisms of ZBEO, transcriptomes by next-generation sequencing technology was implemented to explore the RNA genetic variation on colon tissues. Based on GO analysis and KEGG pathway analysis, a series of genetic pathways involved in the protective role of ZBEO against UC were figured out. As a result, ZBEO treatment could decrease the expression of VCAM-1, TLR8, IL-1β and IL-11 mRNA by qRT-PCR, which are involved in these potential genetic pathways. In conclusion, ZBEO administration would be a medicinal or dietary supplementation strategy for ulcerative colitis treatment.
biochemistry & molecular biology,food science & technology
What problem does this paper attempt to address?